Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
PRVA

PRVA - Privia Health Group, Inc. Stock Price, Fair Value and News

20.48USD+0.49 (+2.45%)Market Closed

Market Summary

PRVA
USD20.48+0.49
Market Closed
2.45%

PRVA Stock Price

View Fullscreen

PRVA RSI Chart

PRVA Valuation

Market Cap

2.4B

Price/Earnings (Trailing)

133.66

Price/Sales (Trailing)

1.45

EV/EBITDA

51.21

Price/Free Cashflow

40.04

PRVA Price/Sales (Trailing)

PRVA Profitability

EBT Margin

1.44%

Return on Equity

3.17%

Return on Assets

1.77%

Free Cashflow Yield

2.5%

PRVA Fundamentals

PRVA Revenue

Revenue (TTM)

1.7B

Rev. Growth (Yr)

7.5%

Rev. Growth (Qtr)

-5.8%

PRVA Earnings

Earnings (TTM)

18.3M

Earnings Growth (Yr)

-59.26%

Earnings Growth (Qtr)

-9.44%

Breaking Down PRVA Revenue

Last 7 days

6.8%

Last 30 days

24.3%

Last 90 days

12.2%

Trailing 12 Months

-21.8%

How does PRVA drawdown profile look like?

PRVA Financial Health

Current Ratio

1.8

PRVA Investor Care

Shares Dilution (1Y)

3.16%

Diluted EPS (TTM)

0.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20241.7B000
20231.4B1.5B1.6B1.7B
20221.1B1.2B1.3B1.4B
2021817.7M860.2M904.6M966.2M
2020794.0M801.7M809.4M817.1M
2019000786.4M
2018000657.6M
PRVA
Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings. It offers technology and population health tools to enhance independent providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; accountable care organization, which engage patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect with new patient populations and create custom contracts. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. is a subsidiary of Brighton Health Group Holdings, LLC.
 CEO
 WEBSITEpriviahealth.com
 INDUSTRYHealthcare Plans
 EMPLOYEES964

Privia Health Group, Inc. Frequently Asked Questions


What is the ticker symbol for Privia Health Group, Inc.? What does PRVA stand for in stocks?

PRVA is the stock ticker symbol of Privia Health Group, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Privia Health Group, Inc. (PRVA)?

As of Fri Jul 26 2024, market cap of Privia Health Group, Inc. is 2.44 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PRVA stock?

You can check PRVA's fair value in chart for subscribers.

Is Privia Health Group, Inc. a good stock to buy?

The fair value guage provides a quick view whether PRVA is over valued or under valued. Whether Privia Health Group, Inc. is cheap or expensive depends on the assumptions which impact Privia Health Group, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PRVA.

What is Privia Health Group, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, PRVA's PE ratio (Price to Earnings) is 133.66 and Price to Sales (PS) ratio is 1.45. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PRVA PE ratio will change depending on the future growth rate expectations of investors.